A23V 2250/0652
Tyrosine
A23V2250/0652 (Tyrosine) appears on 5 US grants and 11 published applications in this corpus.
Search patents in A23V- Granted patents
- 5
- Published applications
- 11
- Assignees
- 6
- Inventors
- 16
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 2 | 1 |
| 2021 | 0 | 2 |
| 2022 | 0 | 2 |
| 2023 | 2 | 3 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Composition for preventing, ameliorating, or treating disease caused by nitration of tyrosine in proteins comprising tyrosine as effective component21 Apr 2026US 12,605,350 B2Industry-Academic Cooperation Foundation Gyeongsang National University
- Deuterated caffeine and uses thereof6 Jun 2023US 11,666,073 B2Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof10 Jan 2023US 11,547,127 B2Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof8 Sep 2020US 10,765,130 B1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof10 Mar 2020US 10,582,716 B1Lennham Pharmaceuticals, Inc.
- Protein particles including an active agent and methods of making and using the same18 Sep 2025US 2025/0288536 A1Corell University
- Deuterated caffeine and uses thereof7 Aug 2025US 2025/0248424 A1Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof29 Aug 2024US 2024/0284942 A1Lannham Pharmaceuticals, Inc,
- Deuterated caffeine and uses thereof23 Nov 2023US 2023/0371555 A1Lennham Pharmaceuticals, Inc.
- Composition for preventing, ameliorating, or treating disease caused by nitration of tyrosine in proteins comprising tyrosine as effective component10 Aug 2023US 2023/0248681 A1Industry-Academic Cooperation Foundation Gyeongsang National University
Most cited
By later US patents
- Deuterated caffeine and uses thereof4US 10,582,716 B1Lennham Pharmaceuticals, Inc. · 2020
- Deuterated caffeine and uses thereof3US 10,765,130 B1Lennham Pharmaceuticals, Inc. · 2020
- Deuterated caffeine and uses thereof1US 11,547,127 B2Lennham Pharmaceuticals, Inc. · 2023
- Deuterated caffeine and uses thereof1US 11,666,073 B2Lennham Pharmaceuticals, Inc. · 2023